Featured Research

from universities, journals, and other organizations

Circulating Blood Cells Are Important Predictors Of Cancer Spread In Children

Date:
July 16, 2009
Source:
American Association for Cancer Research
Summary:
Endothelial progenitor cells may play a role in the start and progression of metastatic disease in children with cancer, according to study results published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

Endothelial progenitor cells may play a role in the start and progression of metastatic disease in children with cancer, according to study results published in Clinical Cancer Research, a journal of the American Association for Cancer Research.

"This is the first study to measure circulating endothelial cells and endothelial progenitor cells in children with cancer, which can provide insight as to the biology of their tumor vessels," said researcher Franηoise Farace, Ph.D., director of the department of biology of circulating cells in the translational research laboratory, Institut Gustave Roussy, France.

"Not only were these cells found in higher levels in patients compared to healthy volunteers, but endothelial progenitor cells were found in strikingly higher amounts in patients with metastatic disease," Farace said.

Circulating endothelial cells are rare cells that shed from the lining of blood vessels after vascular damage. Both circulating endothelial cells and their precursors, endothelial progenitor cells, have been described in previous studies, but mainly in the context of cardiovascular disease.

Farace and colleagues measured circulating mature endothelial cells and bone marrow-derived endothelial progenitor cells in pediatric patients with solid tumors. They collected blood from 23 patients with localized disease, 22 patients with metastatic disease and 20 healthy participants and measured subsets of circulating cells.

While the researchers were not surprised to detect circulating endothelial cells and endothelial progenitor cells in pediatric patients, they were surprised to find these cell levels were significantly higher in patients with metastatic disease compared to levels found in healthy participants.

"This implies that these endothelial cells most likely play a role in the development of cancer in children," Farace said. "We also observed a large range of cell levels in patients with various tumor types. In some cases, very high levels were observed, which means that their role may be very important."

Preclinical studies have shown that these cells play a pivotal role in the initiation of metastasis or the spread of disease in mice; however, their association with metastatic spread has never been demonstrated in humans until now.

"Understanding the process of tumor vessel development in pediatric cancers is of utmost importance as pediatric patients are in dire need of new treatment strategies including those which could target tumor vessels," said researcher Melissa Taylor, M.D., pediatrician and doctoral student in the translational research laboratory, Institut Gustave Roussy, France.

Additional studies are needed in larger study populations to confirm that endothelial progenitor cells are implicated in metastasis. If confirmed, these cells could potentially be measured in patients to allow for early detection of metastatic disease and could be targeted by new drugs to prevent the spread of cancer, according to the researchers.

"This study is very interesting. It demonstrated that these rare cells detected in the blood of adult cancer patients are also important in pediatric cancers," said James L. Abbruzzese, M.D., F.A.C.P., chairman of the department of gastrointestinal medical oncology, M.G. and Lillie A. Johnson chair for cancer treatment and research and professor of medicine at the University of Texas M. D. Anderson Cancer Center. He is also a deputy editor of Clinical Cancer Research.

One challenge with this study Abbruzzese pointed out is defining the characteristics of these cells, which may be more difficult to accomplish in a pediatric population because drawing a large volume of blood is not an easy task.

"Understanding these vascular precursor cells and seeing the changes over time may represent a real strategy for helping to identify drugs that might work in the pediatric population," he said. "Insights as to which patients are likely to develop metastases may help us to identify a subset of patients that require more extensive therapy."

Taylor believes these study results may potentially open new research strategies, which may take into account the study of circulating endothelial cells and progenitor cells in pediatric patients.

"Monitoring of these cells in larger and more homogenous study populations will help us understand the biology of tumor vessels and subsequently tumor growth in these diseases," she said.


Story Source:

The above story is based on materials provided by American Association for Cancer Research. Note: Materials may be edited for content and length.


Cite This Page:

American Association for Cancer Research. "Circulating Blood Cells Are Important Predictors Of Cancer Spread In Children." ScienceDaily. ScienceDaily, 16 July 2009. <www.sciencedaily.com/releases/2009/07/090715074936.htm>.
American Association for Cancer Research. (2009, July 16). Circulating Blood Cells Are Important Predictors Of Cancer Spread In Children. ScienceDaily. Retrieved July 23, 2014 from www.sciencedaily.com/releases/2009/07/090715074936.htm
American Association for Cancer Research. "Circulating Blood Cells Are Important Predictors Of Cancer Spread In Children." ScienceDaily. www.sciencedaily.com/releases/2009/07/090715074936.htm (accessed July 23, 2014).

Share This




More Health & Medicine News

Wednesday, July 23, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Courts Conflicted Over Healthcare Law

Courts Conflicted Over Healthcare Law

AP (July 22, 2014) — Two federal appeals courts issued conflicting rulings Tuesday on the legality of the federally-run healthcare exchange that operates in 36 states. (July 22) Video provided by AP
Powered by NewsLook.com
Why Do People Believe We Only Use 10 Percent Of Our Brains?

Why Do People Believe We Only Use 10 Percent Of Our Brains?

Newsy (July 22, 2014) — The new sci-fi thriller "Lucy" is making people question whether we really use all our brainpower. But, as scientists have insisted for years, we do. Video provided by Newsy
Powered by NewsLook.com
Scientists Find New Way To Make Human Platelets

Scientists Find New Way To Make Human Platelets

Newsy (July 22, 2014) — Boston scientists have discovered a new way to create fully functioning human platelets using a bioreactor and human stem cells. Video provided by Newsy
Powered by NewsLook.com
Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

Gilead's $1000-a-Pill Drug Could Cure Hep C in HIV-Positive People

TheStreet (July 21, 2014) — New research shows Gilead Science's drug Sovaldi helps in curing hepatitis C in those who suffer from HIV. In a medical study, the combination of Gilead's Hep C drug with anti-viral drug Ribavirin cured 76% of HIV-positive patients suffering from the most common hepatitis C strain. Hepatitis C and related complications have been a top cause of death in HIV-positive patients. Typical medication used to treat the disease, including interferon proteins, tended to react badly with HIV drugs. However, Sovaldi's %1,000-a-pill price tag could limit the number of patients able to access the treatment. TheStreet's Keris Lahiff reports from New York. Video provided by TheStreet
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins